Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Medical implants are devices that are placed inside or on the body surface, which are prosthetics, intended to replace missing body parts. Other implants deliver medication, monitor body functions or provide support to organs and tissues. Furthermore, temporary implants such as dental implants, screws, chemotherapy ports and bridges makes most of the next generation implant market due to the increasing number of orthopedic surgeries and also they can be required more than once in a lifetime unlike permanent implants. With the advancement of techniques implants are possible with skin, tissue and bone. Moreover, in next generation implants, the biohybrid implant can act as a future bio-hybrid artificial organ replacement therapy. For instance, autologous dental progenitor cells (DPCs) have the ability to form organized periodontal tissues on titanium implants and can lead to significant improvement in current implant therapies. Additionally, as per U.S. FDA, an implant can be defined as a device or tissue that can be placed on the surface or inside the body. The demand for high-performance orthopaedic implants continues to grow, both for the treatment of bone diseases in an ageing population and for sports-related injuries. In particular, methods are being investigated to encourage the patient’s bone to bond to orthopaedic implants, which would improve implant lifetime and performance.
The next generation implants market is segmented by application, material, end user and geography
The various application of the next generation implants market are covered in the report such as implants, cardiovascular implants, ocular implants and dental implants. Among these, the dental implants segment dominated the next generation implants market in 2018. Increasing incidence of dental diseases, and increasing demand for cosmetic dentistry are contributing to the growth of this segment.
Based on material, the next generation implants market is segmented into metals & metal alloys, ceramics, polymers and biologics. The metals & metal alloys segment dominated the next generation implants market in 2018, owing to the biocompatible nature of metal is the main benefit of its use.
Based on end user, the next generation implants market is segmented into hospitals, ambulatory surgical centers, orthopedic clinics and academic & research institutes. Among these, the hospitals segment dominated the market in 2018. Increasing number of hospitals, modified services & customer service fulfilment and combination treatments are key factors boosting the hospitals segment.
Next Generation Implants Market by Geography
The next generation implants market report is studied across the key countries of North America, Europe, Asia Pacific and Rest of the World. The North America region dominated the next generation implants market in 2018, owing to the rising geriatric population, higher prevalence of diseases and large amount of money invested in R&D and advanced product development in this region. Whereas, Asia Pacific is expected to witness the fastest growth rate during the forecast period.
The market involves various key companies in the global next generation implants market such as Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Danaher Corporation, Dentsply Sirna Inc., Edwards Lifesciences Corporation, Endo International Plc, Globus Medical Inc., Integer Holdings Corporation, Integra LifeSciences Corporation, Institut Straumann AG, Johnson & Johnson, LifeNet Health, Inc., LivaNova PLC, Medtronic Plc, Novartis International AG, Nuvasive, Inc., Orthofix Holdings, Inc., Smith & Nephew plc, Stryker Corporation and Zimmer Biomet Holdings Inc. Market players are involved in new product launches, acquisitions, research & developments to exploit maximum revenue potential in global next generation implants market.
September 2018, Medtronic plc announced the U.S. launch of the Infinity Occipitocervical-Upper Thoracic (OCT) System designed to simplify posterior cervical spine surgery. The Infinity OCT System is a complete procedural solution that integrates navigation and biologics with Medtronic's devices and instrumentation to create efficiency in fusion procedure workflows for the upper back and neck.
May 2018, Medtronic plc announced the launch of a titanium 3D printed platform - TiONIC(TM) Technology - that enables more complex designs and integrated surface technologies for spine surgery implants. TiONIC Technology is a 3D printed technique that creates enhanced surface textures by utilizing a differentiated laser method. Compared with smooth materials, surface texture has been shown to increase osteoconductivity and promote bone response.
August 2017, Globus Medical, Inc., announced that the Excelsius GPS, a revolutionary robotic guidance and navigation system, has been 510(k) cleared by the U.S. Food and Drug Administration. This platform technology supports minimally invasive, open orthopedic and neurosurgical procedures, with screw placement applications in spine and orthopedic surgery.
November 2016, Zimmer Biomet Holdings, Inc., announced the launch of the Comprehensive Vault Reconstruction System (VRS), the first patient-matched glenoid implant cleared to specifically treat patients with a severely deficient rotator cuff and extensive bone loss which precludes the use of a standard glenoid baseplate. The VRS uses CT imaging and advanced 3D reconstruction techniques to allow surgeons to personalize each patient's implant.
March 2016, Zimmer Biomet Holdings, Inc., announced the commercial launch of the Persona Medial Congruent Bearing and OsseoTi Tibial Sleeves for the Vanguard 360 Revision Knee System. These enhancements to Zimmer Biomet's Knee portfolio represent the expansion of two of the Company's flagship knee systems, and combine anatomically inspired designs with cutting-edge advances in implant engineering.
October 2016, Globus Medical, Inc., announced of the launch of the QUARTEX OCT Stabilization System. QUARTEX offers a variety of solutions to the challenges associated with posterior OCT fusion while delivering paramount reliability and ease of use. The system allows surgeons to take full advantage of thoracic anatomy through the use of larger screws with diameters up to 5.5mm.
The next generation implants market is segmented by application, material, end user and geography. The various application of the next generation implants market are covered in the report such as implants, cardiovascular implants, ocular implants and dental implants. Among these, the dental implants segment dominated the next generation implants market in 2018. Increasing incidence of dental diseases, and increasing demand for cosmetic dentistry are contributing to the growth of this segment.
Based on material, the next generation implants market is segmented into metals & metal alloys, ceramics, polymers and biologics. The metals & metal alloys segment dominated the next generation implants market in 2018, owing to the biocompatible nature of metal is the main benefit of its use.
Based on end user, the next generation implants market is segmented into hospitals, ambulatory surgical centers, orthopedic clinics and academic & research institutes. Among these, the hospitals segment dominated the market in 2018. Increasing number of hospitals, modified services & customer service fulfilment and combination treatments are key factors boosting the hospitals segment.
The next generation implants market report is studied across the key countries of North America, Europe, Asia Pacific and Rest of the World. The North America region dominated the next generation implants market in 2018, owing to the rising geriatric population, higher prevalence of diseases and large amount of money invested in R&D and advanced product development in this region.
Why to buy this report:
